Drug Shortage Report for MYLAN-ATORVASTATIN

Last updated on 2020-05-26 History
Report ID 110438
Drug Identification Number 02392976
Brand name MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-05-11
Actual start date
Estimated end date 2020-06-23
Actual end date 2020-05-25
Shortage status Resolved
Updated date 2020-05-26
Company comments Short dated inventory
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-05-26 French Compare
v16 2020-05-26 English Compare
v15 2020-05-12 French Compare
v14 2020-05-12 English Compare
v13 2020-05-06 French Compare
v12 2020-05-06 English Compare
v11 2020-05-06 English Compare
v10 2020-05-01 French Compare
v9 2020-05-01 English Compare
v8 2020-04-29 French Compare
v7 2020-04-29 English Compare
v6 2020-04-21 French Compare
v5 2020-04-21 English Compare
v4 2020-04-07 French Compare
v3 2020-04-07 English Compare
v2 2020-04-02 French Compare
v1 2020-04-02 English Compare

Showing 1 to 17 of 17